ZOMETA in combination with a COX-2 inhibitor and gefitinb cooperatively inhibits growth and angiogenic factor expression and secretion in breast and prostate carcinoma cells
Zoledronic acid (ZOMETA) in combination with a COX-2 inhibitor and gefitinb ('Iressa, ZD1839') cooperatively inhibits growth and angiogenic factor expression and secretion in breast and prostate carcinoma cells
MELISI, Davide;TORTORA, GIAMPAOLO
2003-01-01
Abstract
ZOMETA in combination with a COX-2 inhibitor and gefitinb cooperatively inhibits growth and angiogenic factor expression and secretion in breast and prostate carcinoma cells
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
